Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224 | -3,044 | -2,609 | -1,569 | -653 |
| Depreciation Amortization | 164 | 941 | 749 | 538 | 222 |
| Accounts receivable | -994 | 370 | 304 | 309 | -301 |
| Accounts payable and accrued liabilities | 318 | -379 | -318 | -192 | 218 |
| Other Working Capital | -247 | 338 | 256 | 677 | -671 |
| Other Operating Activity | 822 | 1,964 | 1,707 | 660 | 475 |
| Operating Cash Flow | $-161 | $190 | $88 | $423 | $-711 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 667 | -18 | -13 | -9 |
| PPE Investments | N/A | -47 | -33 | -14 | -10 |
| Other Investing Activity | -29 | -183 | -146 | -88 | -47 |
| Investing Cash Flow | $-29 | $437 | $-197 | $-115 | $-67 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -53 | -53 | -53 | N/A |
| Debt Repayment | -4 | -967 | -33 | -23 | -12 |
| Common Stock Issued | N/A | 22 | N/A | N/A | N/A |
| Other Financing Activity | -165 | 0 | -638 | -417 | -208 |
| Financing Cash Flow | $-169 | $-998 | $-723 | $-492 | $-220 |
| Beginning Cash Position | 1,352 | 1,723 | 1,723 | 1,723 | 1,723 |
| End Cash Position | 994 | 1,352 | 891 | 1,538 | 726 |
| Net Cash Flow | $-358 | $-371 | $-832 | $-185 | $-997 |
| Free Cash Flow | |||||
| Operating Cash Flow | -161 | 190 | 88 | 423 | -711 |
| Capital Expenditure | N/A | -47 | -33 | -14 | -10 |
| Free Cash Flow | -161 | 143 | 56 | 409 | -721 |